137 related articles for article (PubMed ID: 11402025)
21. Insulin-like growth factor-1 (IGF-1) receptor-insulin receptor substrate complexes in the uterus. Altered signaling response to estradiol in the IGF-1(m/m) mouse.
Richards RG; Walker MP; Sebastian J; DiAugustine RP
J Biol Chem; 1998 May; 273(19):11962-9. PubMed ID: 9565625
[TBL] [Abstract][Full Text] [Related]
22. Proinflammatory cytokines block growth of breast cancer cells by impairing signals from a growth factor receptor.
Shen WH; Zhou JH; Broussard SR; Freund GG; Dantzer R; Kelley KW
Cancer Res; 2002 Aug; 62(16):4746-56. PubMed ID: 12183434
[TBL] [Abstract][Full Text] [Related]
23. Conjugated linoleic acid downregulates insulin-like growth factor-I receptor levels in HT-29 human colon cancer cells.
Kim EJ; Kang IJ; Cho HJ; Kim WK; Ha YL; Park JH
J Nutr; 2003 Aug; 133(8):2675-81. PubMed ID: 12888657
[TBL] [Abstract][Full Text] [Related]
24. Genistein inhibits insulin-like growth factor-I receptor signaling in HT-29 human colon cancer cells: a possible mechanism of the growth inhibitory effect of Genistein.
Kim EJ; Shin HK; Park JH
J Med Food; 2005; 8(4):431-8. PubMed ID: 16379552
[TBL] [Abstract][Full Text] [Related]
25.
Hu X; Zheng W; Luo Y; Ou X; Song L; Zhang S; He T; Guo Z; Zhu J; Shi H; Huang W; Yu R
Nutr Cancer; 2020; 72(2):260-272. PubMed ID: 31295033
[No Abstract] [Full Text] [Related]
26. BMP-4 is proteolytically activated by furin and/or PC6 during vertebrate embryonic development.
Cui Y; Jean F; Thomas G; Christian JL
EMBO J; 1998 Aug; 17(16):4735-43. PubMed ID: 9707432
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of insulin-like growth factor signaling pathways in mammary gland by pure antiestrogen ICI 182,780.
Chan TW; Pollak M; Huynh H
Clin Cancer Res; 2001 Aug; 7(8):2545-54. PubMed ID: 11489838
[TBL] [Abstract][Full Text] [Related]
28. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
[TBL] [Abstract][Full Text] [Related]
29. EGCG inhibits activation of the insulin-like growth factor-1 receptor in human colon cancer cells.
Shimizu M; Deguchi A; Hara Y; Moriwaki H; Weinstein IB
Biochem Biophys Res Commun; 2005 Sep; 334(3):947-53. PubMed ID: 16053920
[TBL] [Abstract][Full Text] [Related]
30. Opposing function of the proprotein convertases furin and PACE4 on breast cancer cells' malignant phenotypes: role of tissue inhibitors of metalloproteinase-1.
Lapierre M; Siegfried G; Scamuffa N; Bontemps Y; Calvo F; Seidah NG; Khatib AM
Cancer Res; 2007 Oct; 67(19):9030-4. PubMed ID: 17909005
[TBL] [Abstract][Full Text] [Related]
31. Replacement of tyrosine 1251 in the carboxyl terminus of the insulin-like growth factor-I receptor disrupts the actin cytoskeleton and inhibits proliferation and anchorage-independent growth.
Blakesley VA; Koval AP; Stannard BS; Scrimgeour A; LeRoith D
J Biol Chem; 1998 Jul; 273(29):18411-22. PubMed ID: 9660809
[TBL] [Abstract][Full Text] [Related]
32. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
[TBL] [Abstract][Full Text] [Related]
33. Identification of the myosin heavy polypeptide 9 as a downstream effector of the proprotein convertases in the human colon carcinoma HT-29 cells.
Scamuffa N; Metrakos P; Calvo F; Khatib AM
Methods Mol Biol; 2011; 768():207-15. PubMed ID: 21805244
[TBL] [Abstract][Full Text] [Related]
34. IGF-1 receptor contributes to the malignant phenotype in human and canine osteosarcoma.
MacEwen EG; Pastor J; Kutzke J; Tsan R; Kurzman ID; Thamm DH; Wilson M; Radinsky R
J Cell Biochem; 2004 May; 92(1):77-91. PubMed ID: 15095405
[TBL] [Abstract][Full Text] [Related]
35. The effect of forced expression of mutated K-RAS gene on gastrointestinal cancer cell lines and the IGF-1R targeting therapy.
Matsunaga Y; Adachi Y; Sasaki Y; Koide H; Motoya M; Nosho K; Takagi H; Yamamoto H; Sasaki S; Arimura Y; Tokino T; Carbone DP; Imai K; Shinomura Y
Mol Carcinog; 2017 Feb; 56(2):515-526. PubMed ID: 27312358
[TBL] [Abstract][Full Text] [Related]
36. Up-regulation of insulin-like growth factor binding protein-3 by apigenin leads to growth inhibition and apoptosis of 22Rv1 xenograft in athymic nude mice.
Shukla S; Mishra A; Fu P; MacLennan GT; Resnick MI; Gupta S
FASEB J; 2005 Dec; 19(14):2042-4. PubMed ID: 16230333
[TBL] [Abstract][Full Text] [Related]
37. Growth inhibition of insulin-like growth factor I receptor monoclonal antibody to human colorectal cancer cells.
Zhang Y; Zhang Y
Cancer Invest; 2008; 26(3):230-6. PubMed ID: 18317963
[TBL] [Abstract][Full Text] [Related]
38. Transgenic overexpression of the proprotein convertase furin enhances skin tumor growth.
Fu J; Bassi DE; Zhang J; Li T; Nicolas E; Klein-Szanto AJ
Neoplasia; 2012 Apr; 14(4):271-82. PubMed ID: 22577343
[TBL] [Abstract][Full Text] [Related]
39. Insulin-like growth factor 1 is a potent stimulator of cervical cancer cell invasiveness and proliferation that is modulated by alphavbeta3 integrin signaling.
Shen MR; Hsu YM; Hsu KF; Chen YF; Tang MJ; Chou CY
Carcinogenesis; 2006 May; 27(5):962-71. PubMed ID: 16400188
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of proprotein convertases: approaches to block squamous carcinoma development and progression.
de Cicco RL; Bassi DE; Benavides F; Conti CJ; Klein-Szanto AJ
Mol Carcinog; 2007 Aug; 46(8):654-9. PubMed ID: 17440928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]